{"@context":"https://schema.org","@type":"Corporation","name":"ASTRAZENECA PHARMA IND LT","alternateName":"ASTRAZEN","tickerSymbol":"ASTRAZEN","identifier":"ASTRAZEN","description":"ASTRAZENECA PHARMA IND LT (ASTRAZEN) financials: Market Cap ₹14,926Cr., Price ₹5,970, P/E 86.0, ROE 23.3%. Jun 2026: sales ₹683 Cr, net profit ₹38 Cr. Quarterl…","url":"https://fincrux.org/companies/ASTRAZEN","sameAs":["https://fincrux.org/companies/ASTRAZEN"],"dateModified":"2026-10-18T05:22:30.050231","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹14,926Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹5,970"},{"@type":"PropertyValue","name":"Stock P/E","value":"86.0"},{"@type":"PropertyValue","name":"ROE","value":"23.3%"},{"@type":"PropertyValue","name":"ROCE","value":"29.3%"},{"@type":"PropertyValue","name":"Book Value","value":"₹349"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.60%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹9,850/5,640"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/ASTRAZEN#webpage","name":"ASTRAZENECA PHARMA IND LT (ASTRAZEN) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/ASTRAZEN","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/ASTRAZEN"}}